Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Consensus Recommendation of "Moderate Buy" by Analysts
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twelve research firms that are currently covering the company, Marketbeat...